Clinton Canal, India Breuer, and Jason Wallach in their research laboratories

Development of Non-Hallucinogenic Substituted Tryptamines (SubTryps) for Fragile X Syndrome

FRAXA researchers are developing DPT-based compounds designed to reduce overactive brain activity without hallucinogenic effects in Fragile X syndrome.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (42)